Red White & Bloom Brands (RWBYF)

Overall impact
B (69)

Commentary

Red White & Bloom Brands is a strong overall performer. With a 'B' rating of 69.0 for overall impact (80th percentile compared to all companies), Red White & Bloom Brands ranks 65th out of 154 industry peers, behind Adamis Pharmaceuticals, Benitec Biopharma, Aquinox Pharmaceuticals and 61 others, and ahead of Evolus, Centrexion Therapeutics, GenSight Biologics and 86 others. On top material causes for Red White & Bloom Brands's industry (Pharmaceuticals & Biotech), Red White & Bloom Brands performs well in Child and Maternal Health (95.9 score), Child and Maternal Health (94.0), Access to Affordable Healthcare (96.1) and 4 other causes where it received an 'A' score and performs poorly in Equal Pay and Opportunity (29.6 score), Decent, Safe Work Opportunities (23.1), Reduced Green House Gas Emissions (21.3) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause RWBYF
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1980
Employees
40
Sector
Health Care
Industry
Pharmaceuticals
Sub-industry
Pharmaceuticals
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Bc, Canada
Share classes
RWBYF
Description
Red White & Bloom Brands Inc. manufactures, processes, and distributes cannabis products and accessories primarily in Michigan, California, and Florida. The company operates through Retail and Distribution segments. It also sells non-THC branded products, as well as branded and third-party cannabis products and accessories to the adult-use and medical markets. The company operates licensed adult-use and medical retail dispensaries. The company is based in Vancouver, Canada.
Material causes
Ethos considers the following causes material for Red White & Bloom Brands, based on its industry sub-industry Pharmaceuticals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.